LIVE: Liver Immunocompetent Volumetric Engineering

Carnegie Mellon University in Pittsburgh aims to create a cost-effective immune-silent bioprinted liver that is ready for first-in-human trials in five years. The team will produce human-sized and functional bioprinted livers, initially for acute liver failure with the long-term goal to address all liver failure. 

Back to Award Directory